End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
16.67
CNY
|
+1.46%
|
|
+15.20%
|
-7.80%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,396
|
2,308
|
2,031
|
5,513
|
6,831
|
5,570
|
Enterprise Value (EV)
1 |
1,827
|
1,744
|
1,490
|
5,139
|
6,651
|
5,060
|
P/E ratio
|
46
x
|
38.2
x
|
74.6
x
|
86.5
x
|
83.5
x
|
54
x
|
Yield
|
0.23%
|
0.31%
|
0.15%
|
-
|
-
|
0.55%
|
Capitalization / Revenue
|
1.19
x
|
1.32
x
|
1.4
x
|
2.82
x
|
2.12
x
|
1.82
x
|
EV / Revenue
|
0.91
x
|
1
x
|
1.02
x
|
2.63
x
|
2.06
x
|
1.65
x
|
EV / EBITDA
|
22.2
x
|
18.5
x
|
22.2
x
|
49
x
|
45.7
x
|
29
x
|
EV / FCF
|
43.6
x
|
-114
x
|
-41
x
|
-23.3
x
|
-23.6
x
|
-10.2
x
|
FCF Yield
|
2.29%
|
-0.88%
|
-2.44%
|
-4.29%
|
-4.23%
|
-9.81%
|
Price to Book
|
3.27
x
|
2.84
x
|
2.4
x
|
6.12
x
|
6.9
x
|
3.2
x
|
Nbr of stocks (in thousands)
|
299,150
|
299,150
|
299,150
|
299,150
|
306,325
|
308,081
|
Reference price
2 |
8.009
|
7.714
|
6.790
|
18.43
|
22.30
|
18.08
|
Announcement Date
|
3/25/19
|
3/30/20
|
3/29/21
|
3/18/22
|
4/6/23
|
4/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,011
|
1,745
|
1,456
|
1,952
|
3,222
|
3,067
|
EBITDA
1 |
82.17
|
94.1
|
67.15
|
105
|
145.7
|
174.7
|
EBIT
1 |
57.74
|
71.49
|
43.97
|
78.84
|
96.37
|
120.5
|
Operating Margin
|
2.87%
|
4.1%
|
3.02%
|
4.04%
|
2.99%
|
3.93%
|
Earnings before Tax (EBT)
1 |
69.67
|
84.53
|
39.65
|
88.3
|
103
|
123
|
Net income
1 |
52.07
|
60.3
|
27.14
|
63.79
|
79.97
|
101.1
|
Net margin
|
2.59%
|
3.45%
|
1.86%
|
3.27%
|
2.48%
|
3.3%
|
EPS
2 |
0.1742
|
0.2019
|
0.0910
|
0.2130
|
0.2670
|
0.3350
|
Free Cash Flow
1 |
41.94
|
-15.32
|
-36.33
|
-220.7
|
-281.4
|
-496.2
|
FCF margin
|
2.09%
|
-0.88%
|
-2.5%
|
-11.3%
|
-8.73%
|
-16.18%
|
FCF Conversion (EBITDA)
|
51.04%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
80.53%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0181
|
0.0238
|
0.0100
|
-
|
-
|
0.1000
|
Announcement Date
|
3/25/19
|
3/30/20
|
3/29/21
|
3/18/22
|
4/6/23
|
4/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
568
|
564
|
541
|
374
|
180
|
510
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
41.9
|
-15.3
|
-36.3
|
-221
|
-281
|
-496
|
ROE (net income / shareholders' equity)
|
6.45%
|
7.36%
|
3.21%
|
7.99%
|
9%
|
5.51%
|
ROA (Net income/ Total Assets)
|
4.29%
|
4.91%
|
2.81%
|
4.51%
|
4.68%
|
3.14%
|
Assets
1 |
1,214
|
1,228
|
966.6
|
1,415
|
1,709
|
3,215
|
Book Value Per Share
2 |
2.450
|
2.720
|
2.830
|
3.010
|
3.230
|
5.650
|
Cash Flow per Share
2 |
1.800
|
1.690
|
1.570
|
0.9200
|
0.7800
|
2.980
|
Capex
1 |
13.8
|
31.2
|
137
|
357
|
383
|
819
|
Capex / Sales
|
0.69%
|
1.79%
|
9.4%
|
18.29%
|
11.88%
|
26.69%
|
Announcement Date
|
3/25/19
|
3/30/20
|
3/29/21
|
3/18/22
|
4/6/23
|
4/15/24
|
|
1st Jan change
|
Capi.
|
---|
| -7.80% | 840M | | +4.85% | 105B | | -5.99% | 62.52B | | +72.86% | 49.08B | | +15.33% | 38.99B | | +5.21% | 32.59B | | +13.67% | 20.6B | | +12.59% | 17.19B | | +18.15% | 15.13B | | +3.29% | 14.36B |
Other Commodity Chemicals
|